Isomorphic Labs
Isomorphic Labs is a biotechnology company that focuses on the development of Artificial Intelligence (AI) and Machine Learning (ML) technologies for the advancement of drug discovery and pharmacology. The company is a subsidiary of DeepMind Technologies, a British AI lab owned by Alphabet Inc., the parent company of Google.
Overview[edit | edit source]
Isomorphic Labs was established with the aim of accelerating the process of drug discovery and development by leveraging the power of AI and ML. The company's approach involves the use of advanced computational methods to understand biological systems and predict how they might respond to potential new drugs.
Research and Development[edit | edit source]
The research and development activities at Isomorphic Labs are centered around the application of AI and ML in pharmacology. The company uses these technologies to analyze large volumes of biological data, identify potential drug targets, and predict the effects of potential drugs on these targets. This approach has the potential to significantly speed up the drug discovery process and reduce the cost of developing new drugs.
Collaborations[edit | edit source]
Isomorphic Labs collaborates with a number of other organizations in the field of biotechnology and pharmacology. These collaborations are aimed at leveraging the expertise of these organizations to further the company's research and development efforts.
Challenges and Criticisms[edit | edit source]
While the use of AI and ML in drug discovery holds great promise, it also presents a number of challenges. These include the need for large volumes of high-quality data, the complexity of biological systems, and the difficulty of predicting the effects of potential drugs on these systems. In addition, there have been criticisms of the lack of transparency in the use of AI and ML in drug discovery, and concerns about the potential for these technologies to be used in ways that could harm patients or the public.
See Also[edit | edit source]
- DeepMind Technologies
- Artificial Intelligence in Drug Discovery
- Machine Learning in Pharmacology
- Alphabet Inc.
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
